Christopher Kramer, M.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Cytokinetics
    Topic:
    HCM
    Date added:
    09/04/2026
    Date updated:
    09/04/2026
    Relationship end date:
    09/01/2027
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Eli Lilly
    Topic:
    HFpEF
    Date added:
    09/04/2026
    Date updated:
    09/04/2026
    Relationship end date:
    09/01/2027
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Eli Lilly
    Topic:
    HFpEF
    Date added:
    09/04/2026
    Date updated:
    09/04/2026
    Relationship end date:
    09/01/2027
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Sanofi
    Topic:
    HCM
    Date added:
    09/04/2026
    Date updated:
    09/04/2026
    Relationship end date:
    07/31/2027
Return to Washington ACC 2026 Annual Meeting